SG Patents Fast Suspended: 5 Alternative Filing Strategies for Singapore Patent Applicants in 2026

For tech startups, biotech firms, and legal teams planning their intellectual property strategies in Singapore, a major curveball arrived at the start of the year. Effective January 4, 2026, the Intellectual Property Office of Singapore (IPOS) officially suspended its SG Patents Fast and SG Trade Marks Fast acceleration programmes under Patents Circular No. 1/2026.

If you filed your acceleration request before the January 4 cut-off, the IPOS will honour the fast-track timelines. However, if you missed the deadline, you can no longer use the domestic fast-track route that promised a first official office action within 4 to 8 months.

Missing this cut-off disrupts critical commercial milestones—whether that is securing Series B funding, finalizing cross-border licensing deals, or securing grants from the Health Sciences Authority (HSA) for medical device registrations.

Fortunately, the suspension of SG Patents Fast does not mean that your patent application grinds to a halt. By pivoting your approach with experienced partners like Pintas Singapore, you can deploy alternative legal mechanisms to keep your application on an expedited track.

Here are 5 alternative patent filing strategies you can utilize right now to navigate the 2026 IPOS suspension.

1. Deploy the Patent Prosecution Highway (PPH) & Global PPH

If you are pursuing an international IP strategy, the Patent Prosecution Highway (PPH) is currently your strongest alternative to SG Patents Fast.

The PPH allows you to fast-track examination at the IPOS if you have already received a positive examination report or allowable claims from a partner IP office. The IPOS maintains a vast network of over 30 PPH partners, including major global jurisdictions like the United States (USPTO), European Union (EPO), China (CNIPA), Japan (JPO), and South Korea (KIPO).

The 2026 Advantage: According to updated IPOS data, patents processed via the PPH enjoy a massive 94% grant rate in Singapore. Furthermore, approximately 70% of these patents are granted after the first office action, usually within 10 months of the PPH request.To initiate this, you must file Patents Form 11 or 12, select the “ASPEC/PPH” checkbox, and ensure that your Singapore patent claims are amended to match the approved foreign claims.

2. Utilize the ASEAN Patent Examination Co-operation (ASPEC)

If your primary market expansion targets are in Southeast Asia, ASPEC is a highly effective regional acceleration framework.

ASPEC allows participating ASEAN IP offices 

ï  Brunei Darussalam

ï  Cambodia

ï  Indonesia

ï  Lao PDR (Laos)

ï  Malaysia

ï  The Philippines

ï  Singapore

ï  Thailand

ï  Vietnam 

to share search and examination results. If you obtain a favourable search and examination report from any participating ASEAN country, you can submit those results to the IPOS to significantly trigger a faster local review by the IPOS.

Why choose ASPEC in 2026?

• Cost-Efficient: Unlike domestic fast-track programmes that require hefty premium acceleration fees, ASPEC operates on a shared infrastructure, minimizing added official fees.
• Regional Consistency: It streamlines your overall commercialization roadmap across multiple ASEAN territories simultaneously.

3. Opt for PCT-PPH (Using International Search Reports)

Many applicants who intended to use SG Patents Fast are also processing an international application via the Patent Cooperation Treaty (PCT). If you have filed a PCT application and received a clean International Preliminary Report on Patentability (IPRP) or a positive Written Opinion from an International Searching Authority (ISA), you can jump directly onto the PCT-PPH track.

When entering the Singaporean national phase, you can use these positive international results to request accelerated examination at the IPOS. This bypasses the standard domestic queue without relying on the suspended SG Patents Fast framework.

4. Rely on the “Favorable Foreign Grant” Route (Modified Examination)

Singapore runs on a flexible patent system that allows for Modified Examination. If you have a corresponding foreign application that has already proceeded to a grant in an approved jurisdiction (the US, UK, EP, Japan, or Australia), you can rely entirely on that foreign grant to secure your Singaporean patent.

Instead of undergoing a full, independent local search and examination by an IPOS Examiner, you submit the certified copy of the foreign patent specification and conform your Singapore claims to match. This significantly simplifies the local process, reducing both the time to grant and the likelihood of receiving any form of local objection.

5. Implement Tightened Trade Secret Controls During the Delay

If your technology is strictly localized to Singapore, or if you do not have any foreign corresponding applications to trigger a PPH or ASPEC track, your application will follow the standard IPOS examination timeline.

Because standard prosecution can take significantly longer without acceleration, you must protect your commercial advantage in the interim by tightening your Trade Secret and Confidentiality Frameworks.

Under Singapore common law, protecting proprietary data relies heavily on proving a breach of confidence or contract. While your patent is pending in the slower standard queue:

• Implement robust Non-Disclosure Agreements (NDAs) for all vendor and investor discussions.
• Enforce strict role-based data access controls within your engineering and R&D teams.
• Ensure codebases, manufacturing protocols, and chemical formulations remain hidden until the official publication date (typically 18 months from the priority date).

Strategic Summary: Comparing Your Post-Suspension Options

Frequently Asked Questions (FAQ)

• Why did the IPOS suspend the SG Patents Fast programme?

According to Patents Circular No. 1/2026, IPOS placed the SG Patents Fast and SG Trade Marks Fast programmes under review to evaluate their structural efficacy. The office has not provided a specific date for reinstatement or detailed what modifications might be introduced.

• I filed my acceleration request right before January 4, 2026. Will it still be processed?

Yes. The IPOS has confirmed that all qualifying acceleration requests received before the January 4, 2026 cut-off will be fully honoured and processed under the expedited 4-month or 8-month timelines.

• Can I still use ASPEC if my primary application is filed in Singapore?

Yes. If you choose Singapore as your office of first filing, you can submit your positive IPOS search and examination reports to accelerate your corresponding applications in other ASEAN countries like Malaysia or Thailand. Conversely, you can use reports from those countries to speed up the prosecution of your application in Singapore.

• How do the April 2026 IPOS fee changes impact my strategy?

Effective April 1, 2026, the IPOS revised its fee structure, particularly adjusting excess claim fees (now payable when requesting examination) and capping uncharged claims at 15 instead of 20. When considering alternative routes like the PPH or Modified Examination, it is critical to trim and conform your claims early, to avoid unexpected cost overruns under these new rules.

• How Pintas Singapore Can Help Secure Your IP Timeline

Navigating the IP landscape after the sudden suspension of a major acceleration programme requires proactive, strategic adjustments. You do not have to let your funding rounds or product launches stall while waiting in a standard examination queue.

At Pintas Singapore, our team specializes in cross-border patent prosecution, and redirection strategies, through the use of  international frameworks like the PPH and ASPEC. We can evaluate your current patent portfolio, identify valid foreign matching claims, and successfully pivot your Singapore applications onto alternative fast tracks.

Take Action: Secure Your Fast-Track Timeline Today

Don’t let regulatory updates delay your commercial milestones. Contact our patent specialists today to audit your portfolio and map out your alternative path to a Singapore patent grant.

📍 Address: Suite 12-14, Manhattan House, 151 Chin Swee Rd, Singapore 169876
Singapore Company Directory

📞 Phone: +65 9747 2579

✉️ Email: pintas.sg@pintas-ip.com

🌐 Website: pintas-ip.com